Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

BPC 157 therapy and the permanent occlusion of the superior sagittal sinus in rat: vascular recruitment (CROSBI ID 300050)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Gojković, Slaven ; Krezić, Ivan ; Vraneš, Hrvoje ; Žižek, Helena ; Drmić, Domagoj ; Horvat Pavlov, Katarina ; Petrović, Andreja ; Batelja Vuletić, Lovorka ; Milavić, Marija ; Sikirić, Sunčana et al. BPC 157 therapy and the permanent occlusion of the superior sagittal sinus in rat: vascular recruitment // Biomedicines, 9 (2021), 7; 744, 33. doi: 10.3390/biomedicines9070744

Podaci o odgovornosti

Gojković, Slaven ; Krezić, Ivan ; Vraneš, Hrvoje ; Žižek, Helena ; Drmić, Domagoj ; Horvat Pavlov, Katarina ; Petrović, Andreja ; Batelja Vuletić, Lovorka ; Milavić, Marija ; Sikirić, Sunčana ; Stilinović, Irma ; Samara, Mariam ; Knežević, Mario ; Barišić, Ivan ; Sjekavica, Ivica ; Lovrić, Eva ; Škrtić, Anita ; Seiwerth, Sven ; Sikirić, Predrag

hrvatski

BPC 157 therapy and the permanent occlusion of the superior sagittal sinus in rat: vascular recruitment

We show the complex syndrome of the occluded superior sagittal sinus, brain swelling and lesions and multiple peripheral organs lesions in rat. Recovery goes centrally and peripherally, with the stable gastric pentadecapeptide BPC 157, which alleviated peripheral vascular occlusion disturbances, rapidly activating alternative bypassing pathways. Assessments were gross recording, venography, ECG, pressure, microscopy, biochemistry. The increased pressure in the superior sagittal sinus, portal and caval hypertension, aortal hypotension, arterial and venous thrombosis, severe brain swelling and lesions (cortex (cerebral, cerebellar), hypothalamus/thalamus, hippocampus), particular veins (azygos, superior mesenteric, inferior caval) dysfunction, heart dysfunction, lung congestion as acute respiratory distress syndrome, kidney disturbances, liver failure, and hemorrhagic lesions in gastrointestinal tract were all assessed. Rats received BPC 157 medication (10 µg/kg, 10 ng/kg) intraperitoneally, intragastrically, or topically to the swollen brain at 1 min ligation-time, or at 15 min, 24 h and 48 h ligation-time. BPC 157 therapy rapidly attenuates the brain swelling, rapidly eliminates the increased pressure in the ligated superior sagittal sinus and the severe portal and caval hypertension and aortal hypotension, and rapidly recruits collateral vessels, centrally ((para)sagittal venous collateral circulation) and peripherally (left superior caval vein azygos vein-inferior caval vein). In conclusion, as shown by all assessments, BPC 157 acts against the permanent occlusion of the superior sagittal sinus and syndrome (i.e., brain, heart, lung, liver, kidney, gastrointestinal lesions, thrombosis), given at 1 min, 15 min, 24 h or 48 h ligation- time. BPC 157 therapy rapidly overwhelms the permanent occlusion of the superior sagittal sinus in ra

BPC 157 ; superior sagittal sinus ; occlusion ; therapy ; vascular recruitment ; rats

nije evidentirano

engleski

BPC 157 therapy and the permanent occlusion of the superior sagittal sinus in rat: vascular recruitment

nije evidentirano

BPC 157 ; superior sagittal sinus ; occlusion ; therapy ; vascular recruitment ; rats

nije evidentirano

Podaci o izdanju

9 (7)

2021.

744

33

objavljeno

2227-9059

10.3390/biomedicines9070744

Trošak objave rada u otvorenom pristupu

Povezanost rada

Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)

Poveznice
Indeksiranost